Physician profile
Duke A Phan
NPI 1437352630
$2,798.71
in general payments reported to CMS, 2019-2025
18 companies · $744 in 2025
The $744 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.34 · 2020: $170 · 2021: $244 · 2022: $923 · 2023: $340 · 2024: $278 · 2025: $744.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,361.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $533.11 | 2022-2025 | Ingrezza |
| Astrazeneca Pharmaceuticals LP | $371.90 | 2021-2025 | Tezspire |
| Sk Life Science, INC. | $248.60 | 2022-2023 | Xcopri |
| Amgen INC. | $241.63 | 2020-2021 | |
| Abbvie INC. | $181.67 | 2022-2023 | |
| Eisai INC. | $146.24 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $124.24 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $123.28 | 2022 | |
| Alexion Pharmaceuticals, INC. | $120.19 | 2025 | Ultomiris |
| Pfizer INC. | $120.08 | 2025 | |
| Argenx US, INC. | $114.98 | 2025 | Vyvgart |
| Lilly USA, LLC | $111.92 | 2025 | Kisunla |
| Acadia Pharmaceuticals INC | $108.74 | 2022 | |
| Emd Serono, INC. | $99.34 | 2019 | |
| Genentech, INC. | $78.81 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $24.90 | 2020 | |
| Allergan, INC. | $24.73 | 2020 | |
| Merck Sharp & Dohme LLC | $24.35 | 2024 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Duke Phan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.